TF and cancer: Current data so far do not suggest diagnostic relevance, consistently with the lack of specificity and the wide distribution range of this biomarker, but rather a potential role in the prognostic stratification of patients with well-defined clinical conditions in whom TF overexpression may have harmful effects (like cardiovascular disease or cancer).